Published on 23 Dec 2023 on Simply Wall St. via Yahoo Finance
With 85% ownership of the shares, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is heavily dominated by...
Key Insights
Institutions' substantial holdings in Syndax Pharmaceuticals implies that they have significant influence over the company's share priceThe top 12 shareholders own 51% of the companyOwnership research along with analyst forecasts data help provide a good understanding of opportunities in a stock
To get a sense of who is truly in control of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX), it is important to understand the ownership structure of the business. With 85% stake, institutions possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).